111 related articles for article (PubMed ID: 22824479)
1. A myriad of pathways to NASH.
Larrain S; Rinella ME
Clin Liver Dis; 2012 Aug; 16(3):525-48. PubMed ID: 22824479
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis and the metabolic syndrome.
Jiang J; Torok N
Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
[TBL] [Abstract][Full Text] [Related]
4. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
5. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
6. Evolving trends in nonalcoholic fatty liver disease.
Delgado JS
Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
[TBL] [Abstract][Full Text] [Related]
7. From the metabolic syndrome to NAFLD or vice versa?
Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
9. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.
Willner IR; Waters B; Patil SR; Reuben A; Morelli J; Riely CA
Am J Gastroenterol; 2001 Oct; 96(10):2957-61. PubMed ID: 11693332
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced steatohepatitis.
Stravitz RT; Sanyal AJ
Clin Liver Dis; 2003 May; 7(2):435-51. PubMed ID: 12879993
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Tiniakos DG
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
13. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
Koike K; Moriya K
J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
[TBL] [Abstract][Full Text] [Related]
14. Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH).
Yamagishi S; Nakamura K; Inoue H
Med Hypotheses; 2005; 65(2):377-9. PubMed ID: 15922116
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis.
Amarapurkar DN; Patel ND
Trop Gastroenterol; 2004; 25(3):125-9. PubMed ID: 15682659
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease and lipids.
Wierzbicki AS; Oben J
Curr Opin Lipidol; 2012 Aug; 23(4):345-52. PubMed ID: 22617751
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced hepatic steatosis.
Amacher DE; Chalasani N
Semin Liver Dis; 2014 May; 34(2):205-14. PubMed ID: 24879984
[TBL] [Abstract][Full Text] [Related]
18. [Non-alcoholic steatohepatitis].
Duvnjak M; Virović L
Acta Med Croatica; 2003; 57(3):189-99. PubMed ID: 14582465
[TBL] [Abstract][Full Text] [Related]
19. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
Chalasani N; Deeg MA; Crabb DW
Am J Gastroenterol; 2004 Aug; 99(8):1497-502. PubMed ID: 15307867
[TBL] [Abstract][Full Text] [Related]
20. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]